Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Nov;60(5):693–700. doi: 10.1038/bjc.1989.342

The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up.

S Toikkanen 1, H Joensuu 1, P Klemi 1
PMCID: PMC2247288  PMID: 2553094

Abstract

The nuclear DNA content of 351 breast carcinomas was determined by flow cytometry from paraffin-embedded tissue to assess the prognostic significance of DNA ploidy, the DNA index (DI) and the S-phase fraction (SPF). The minimum follow-up of the patients was 22 years, and they were all from a defined urban population. DNA ploidy correlated with histological type and grade, mitotic count and nuclear pleomorphism (P less than 0.0001), and also with axillary nodal status (P = 0.0005), tumour necrosis (P = 0.001), primary tumour size (P = 0.03), menopausal status (P = 0.004) and the presence of distant metastases at the time of the diagnosis (P = 0.04). Survival corrected for intercurrent deaths of the patients with a diploid tumour was better than that of the patients with a non-diploid tumour (P = 0.0001, 48% vs 28% at 25 years). SPF had prognostic significance in both axillary node positive and negative patients, but ploidy and DI only in the node negative group, and their significance was greater in post-menopausal than in premenopausal patients. Axillary nodal status, primary tumour size, histological grade and the type of tumour margin circumscription were the most important independent prognostic factors in Cox's multivariate analysis, and SPF had independent prognostic value, whereas ploidy and DI did not. It is concluded that DNA ploidy, DI and SPF have long-term prognostic significance in breast cancer.

Full text

PDF
693

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baak J. P., Van Dop H., Kurver P. H., Hermans J. The value of morphometry to classic prognosticators in breast cancer. Cancer. 1985 Jul 15;56(2):374–382. doi: 10.1002/1097-0142(19850715)56:2<374::aid-cncr2820560229>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  2. Baildam A. D., Zaloudik J., Howell A., Barnes D. M., Turnbull L., Swindell R., Moore M., Sellwood R. A. DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast. Br J Cancer. 1987 May;55(5):553–559. doi: 10.1038/bjc.1987.113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baisch H., Göhde W., Linden W. A. Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle. Radiat Environ Biophys. 1975 Jun 13;12(1):31–39. doi: 10.1007/BF02339807. [DOI] [PubMed] [Google Scholar]
  4. Cornelisse C. J., van de Velde C. J., Caspers R. J., Moolenaar A. J., Hermans J. DNA ploidy and survival in breast cancer patients. Cytometry. 1987 Mar;8(2):225–234. doi: 10.1002/cyto.990080217. [DOI] [PubMed] [Google Scholar]
  5. Coulson P. B., Thornthwaite J. T., Woolley T. W., Sugarbaker E. V., Seckinger D. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival. Cancer Res. 1984 Sep;44(9):4187–4196. [PubMed] [Google Scholar]
  6. Dowle C. S., Owainati A., Robins A., Burns K., Ellis I. O., Elston C. W., Blamey R. W. Prognostic significance of the DNA content of human breast cancer. Br J Surg. 1987 Feb;74(2):133–136. doi: 10.1002/bjs.1800740221. [DOI] [PubMed] [Google Scholar]
  7. Dressler L. G., Seamer L. C., Owens M. A., Clark G. M., McGuire W. L. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer. 1988 Feb 1;61(3):420–427. doi: 10.1002/1097-0142(19880201)61:3<420::aid-cncr2820610303>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  8. Ewers S. B., Långström E., Baldetorp B., Killander D. Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations. Cytometry. 1984 Jul;5(4):408–419. doi: 10.1002/cyto.990050419. [DOI] [PubMed] [Google Scholar]
  9. Feichter G. E., Mueller A., Kaufmann M., Haag D., Born I. A., Abel U., Klinga K., Kubli F., Goerttler K. Correlation of DNA flow cytometric results and other prognostic factors in primary breast cancer. Int J Cancer. 1988 Jun 15;41(6):823–828. doi: 10.1002/ijc.2910410608. [DOI] [PubMed] [Google Scholar]
  10. Fisher E. R., Sass R., Fisher B. Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (protocol no. 4). X. Discriminants for tenth year treatment failure. Cancer. 1984 Feb 1;53(3 Suppl):712–723. doi: 10.1002/1097-0142(19840201)53:3+<712::aid-cncr2820531320>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  11. Haag D., Goerttler K., Tschahargane C. The proliferative index (PI) of human breast cancer as obtained by flow cytometry. Pathol Res Pract. 1984 Mar;178(4):315–322. doi: 10.1016/S0344-0338(84)80020-5. [DOI] [PubMed] [Google Scholar]
  12. Hedley D. W., Friedlander M. L., Taylor I. W., Rugg C. A., Musgrove E. A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem. 1983 Nov;31(11):1333–1335. doi: 10.1177/31.11.6619538. [DOI] [PubMed] [Google Scholar]
  13. Hedley D. W., Rugg C. A., Gelber R. D. Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer. Cancer Res. 1987 Sep 1;47(17):4729–4735. [PubMed] [Google Scholar]
  14. Hedley D. W., Rugg C. A., Ng A. B., Taylor I. W. Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients. Cancer Res. 1984 Nov;44(11):5395–5398. [PubMed] [Google Scholar]
  15. Hsu S. M., Raine L., Nayak R. N. Medullary carcinoma of breast: an immunohistochemical study of its lymphoid stroma. Cancer. 1981 Sep 15;48(6):1368–1376. doi: 10.1002/1097-0142(19810915)48:6<1368::aid-cncr2820480619>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  16. Jakobsen A., Poulsen H. S., Madsen E. L., Petersen S. E., Hansen H. S. Ploidy level of human breast carcinoma. Relation to histopathologic features and hormone receptor content. Acta Radiol Oncol. 1984;23(2-3):103–107. doi: 10.3109/02841868409135997. [DOI] [PubMed] [Google Scholar]
  17. Joensuu H., Klemi P. J. DNA aneuploidy in adenomas of endocrine organs. Am J Pathol. 1988 Jul;132(1):145–151. [PMC free article] [PubMed] [Google Scholar]
  18. Kallioniemi O. P., Blanco G., Alavaikko M., Hietanen T., Mattila J., Lauslahti K., Koivula T. Tumour DNA ploidy as an independent prognostic factor in breast cancer. Br J Cancer. 1987 Nov;56(5):637–642. doi: 10.1038/bjc.1987.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kallioniemi O. P., Blanco G., Alavaikko M., Hietanen T., Mattila J., Lauslahti K., Lehtinen M., Koivula T. Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer. Cancer. 1988 Nov 15;62(10):2183–2190. doi: 10.1002/1097-0142(19881115)62:10<2183::aid-cncr2820621019>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  20. Klemi P. J., Joensuu H., Kiilholma P., Mäenpä J. Clinical significance of abnormal nuclear DNA content in serous ovarian tumors. Cancer. 1988 Nov 1;62(9):2005–2010. doi: 10.1002/1097-0142(19881101)62:9<2005::aid-cncr2820620922>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  21. Kuhajda F. P., Eggleston J. C. Pregnancy-associated plasma protein A and extensive necrosis. Clinically significant predictors of early recurrence in stage I estrogen receptor-negative breast carcinoma. Lab Invest. 1985 Jul;53(1):101–107. [PubMed] [Google Scholar]
  22. Kute T. E., Muss H. B., Hopkins M., Marshall R., Case D., Kammire L. Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer. Breast Cancer Res Treat. 1985;6(2):113–121. doi: 10.1007/BF02235742. [DOI] [PubMed] [Google Scholar]
  23. Leathem A. J., Brooks S. A. Predictive value of lectin binding on breast-cancer recurrence and survival. Lancet. 1987 May 9;1(8541):1054–1056. doi: 10.1016/s0140-6736(87)90482-x. [DOI] [PubMed] [Google Scholar]
  24. McDivitt R. W., Stone K. R., Craig R. B., Palmer J. O., Meyer J. S., Bauer W. C. A proposed classification of breast cancer based on kinetic information: derived from a comparison of risk factors in 168 primary operable breast cancers. Cancer. 1986 Jan 15;57(2):269–276. doi: 10.1002/1097-0142(19860115)57:2<269::aid-cncr2820570214>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  25. Moran R. E., Black M. M., Alpert L., Straus M. J. Correlation of cell-cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer. Cancer. 1984 Oct 15;54(8):1586–1590. doi: 10.1002/1097-0142(19841015)54:8<1586::aid-cncr2820540820>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  26. Olszewski W., Darzynkiewicz Z., Rosen P. P., Schwartz M. K., Melamed M. R. Flow cytometry of breast carcinoma: II. Relation of tumor cell cycle distribution to histology and estrogen receptor. Cancer. 1981 Aug 15;48(4):985–988. doi: 10.1002/1097-0142(19810815)48:4<985::aid-cncr2820480422>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  27. Owainati A. A., Robins R. A., Hinton C., Ellis I. O., Dowle C. S., Ferry B., Elston C. W., Blamey R. W., Baldwin R. W. Tumour aneuploidy, prognostic parameters and survival in primary breast cancer. Br J Cancer. 1987 Apr;55(4):449–454. doi: 10.1038/bjc.1987.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shek L. L., Godolphin W. Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis. Cancer Res. 1988 Oct 1;48(19):5565–5569. [PubMed] [Google Scholar]
  29. Slamon D. J., Clark G. M., Wong S. G., Levin W. J., Ullrich A., McGuire W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987 Jan 9;235(4785):177–182. doi: 10.1126/science.3798106. [DOI] [PubMed] [Google Scholar]
  30. Spyratos F., Briffod M., Gentile A., Brunet M., Brault C., Desplaces A. Flow cytometric study of DNA distribution in cytopunctures of benign and malignant breast lesions. Anal Quant Cytol Histol. 1987 Dec;9(6):485–494. [PubMed] [Google Scholar]
  31. Stål O., Wingren S., Carstensen J., Rutqvist L. E., Skoog L., Klintenberg C., Nordenskjöld B. Prognostic value of DNA ploidy and S-phase fraction in relation to estrogen receptor content and clinicopathological variables in primary breast cancer. Eur J Cancer Clin Oncol. 1989 Feb;25(2):301–309. doi: 10.1016/0277-5379(89)90023-0. [DOI] [PubMed] [Google Scholar]
  32. Taylor I. W., Musgrove E. A., Friedlander M. L., Foo M. S., Hedley D. W. The influence of age on the DNA ploidy levels of breast tumours. Eur J Cancer Clin Oncol. 1983 May;19(5):623–628. doi: 10.1016/0277-5379(83)90178-5. [DOI] [PubMed] [Google Scholar]
  33. Thorud E., Fosså S. D., Vaage S., Kaalhus O., Knudsen O. S., Børmer O., Shoaib M. C. Primary breast cancer. Flow cytometric DNA pattern in relation to clinical and histopathologic characteristics. Cancer. 1986 Feb 15;57(4):808–811. doi: 10.1002/1097-0142(19860215)57:4<808::aid-cncr2820570421>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  34. Toikkanen S., Eerola E., Ekfors T. O. Pure and mixed mucinous breast carcinomas: DNA stemline and prognosis. J Clin Pathol. 1988 Mar;41(3):300–303. doi: 10.1136/jcp.41.3.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Uyterlinde A. M., Schipper N. W., Baak J. P., Peterse H., Matze E. Limited prognostic value of cellular DNA content to classical and morphometrical parameters in invasive ductal breast cancer. Am J Clin Pathol. 1988 Mar;89(3):301–307. doi: 10.1093/ajcp/89.3.301. [DOI] [PubMed] [Google Scholar]
  36. Vindeløv L. L., Christensen I. J., Nissen N. I. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry. 1983 Mar;3(5):323–327. doi: 10.1002/cyto.990030503. [DOI] [PubMed] [Google Scholar]
  37. van der Linden J. C., Lindeman J., Baak J. P., Meijer C. J., Herman C. J. The Multivariate Prognostic Index and nuclear DNA content are independent prognostic factors in primary breast cancer patients. Cytometry. 1989 Jan;10(1):56–61. doi: 10.1002/cyto.990100110. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES